![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Fresenius Kabi Ipsum S.r.l. Cassina De’ Pecchi It, based in Italy, is a pharmaceutical company.
One of their significant offerings is Pivmecillinam hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2004-262 - Rev 07
This Chemical Type CEP, issued on June 12, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1359 associated with this CEP further emphasizes